Titlebook: ;

CORE

Novel Antibiotics in Urologye last 10?years are considered including one new siderophore cephalosporin, two new carbapenems, three cephalosporin/beta-lactamase inhibitor and two carbapenem/beta-lactamase inhibitor combinations, one novel aminoglycoside, two new fluoroquinolones, a new tetracycline, and the revival of the parenteral fosfomycin disodium.

Encumber

姑姑在炫耀

豐滿中國(guó)

GRATE

刺穿

The Treatment of Urinary Tract Infections Caused by ESBL-Producing Gram-Negative Bacteria, Vancomyciatients with urinary tract infections (UTI) caused by ESBL, VRE, and MDR bacteria..This chapter aims to comprehensively discuss current antibacterial treatment options for uncomplicated and complicated UTI caused by multiresistant microorganisms and to provide an overview of currently available as well as upcoming therapeutic options.

臆斷

Bacteriophage Therapy for Urinary Tract Infections., we delve into the specific clinical applications of phages for treating urinary tract infections (UTIs) in patients and provide our perspective on the future of phage therapy in combating urological infections.